Protalix BioTherapeutics (PLX) Interest Coverage Ratio Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5,448.29% |
| Dec 31, 2024 | 2,523.72% |
| Sep 30, 2024 | 474.19% |
| Jun 30, 2024 | -140.92% |
| Mar 31, 2024 | -228.62% |
| Dec 31, 2023 | -162.91% |
| Sep 30, 2023 | 16.12% |
| Jun 30, 2023 | 276.48% |
| Mar 31, 2023 | -25.22% |
| Dec 31, 2022 | 283.51% |
| Sep 30, 2022 | -525.25% |
| Jun 30, 2022 | -113.11% |
| Mar 31, 2022 | -76.08% |
| Dec 31, 2021 | -658.02% |
| Sep 30, 2021 | 40.23% |
| Jun 30, 2021 | -261.83% |
| Mar 31, 2021 | -218.24% |
| Dec 31, 2020 | 6.93% |
| Sep 30, 2020 | -73.75% |
| Jun 30, 2020 | 62.44% |
| Mar 31, 2020 | 150.42% |
| Dec 31, 2019 | 153.37% |
| Sep 30, 2019 | 63.54% |
| Jun 30, 2019 | 18.60% |
| Mar 31, 2019 | -24.22% |
| Dec 31, 2018 | 81.14% |
| Sep 30, 2018 | 2.10% |
| Jun 30, 2018 | -6.00% |
| Mar 31, 2018 | 23.92% |
| Dec 31, 2017 | -77.18% |
| Sep 30, 2017 | 71.12% |
| Jun 30, 2017 | 67.81% |
| Mar 31, 2017 | 64.94% |
| Dec 31, 2016 | 28.69% |
| Sep 30, 2016 | -50.43% |
| Jun 30, 2016 | -26.72% |
| Mar 31, 2016 | -86.94% |
| Mar 31, 2015 | 34.17% |
| Mar 31, 2014 | 97.77% |